Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene

Zhili Lin, Gael Carney, William B Rizzo

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Fatty aldehyde dehydrogenase (FALDH) is a microsomal enzyme that catalyzes the oxidation of aliphatic aldehydes to fatty acids. Mutations in the FALDH gene are responsible for the human genetic disorder Sjogren-Larsson syndrome (SLS) which is characterized by ichthyosis, mental retardation, and spasticity. To better understand SLS and the expression of FALDH in mammalian tissues, we investigated the organization and expression of the mouse FALDH gene (recently named ALDH3A2). The mouse gene consists of 11 exons and spans about 25 kb. Primer extension experiments identified the transcription initiation site at nt -121 relative to the translation initiating codon. The major FALDH transcript was 3 kb long and was composed of exons 1-10. A less abundant alternately spliced transcript contained an additional exon (exon 9') inserted between exons 9 and 10 and encodes a protein (FALDHυ) with a variant carboxy-terminal domain of unknown function. Northern analysis using RNA from different tissues showed widespread but variable expression of the gene, which generally correlated with FALDH enzyme activity. Expression of the alternate exon 9' transcript in tissues often differed from that of the major transcript and did not reflect enzyme activity. These results provide a basis for investigating the in vivo expression of FALDH in response to physiologic and pharmacologic manipulation, and are essential for the development of an animal model of SLS. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)496-505
Number of pages10
JournalMolecular Genetics and Metabolism
Volume71
Issue number3
DOIs
StatePublished - Jan 1 2000

Fingerprint

long-chain-aldehyde dehydrogenase
Alternative Splicing
Genes
Exons
Sjogren-Larsson Syndrome
Enzyme activity
Tissue
Enzymes
Ichthyosis
Inborn Genetic Diseases
Transcription Initiation Site
Medical Genetics

Keywords

  • Alternate splicing
  • Enzyme
  • Fatty aldehyde
  • Fatty aldehyde dehydrogenase
  • Ichthyosis
  • Mental retardation
  • Sjogren-Larsson syndrome

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene. / Lin, Zhili; Carney, Gael; Rizzo, William B.

In: Molecular Genetics and Metabolism, Vol. 71, No. 3, 01.01.2000, p. 496-505.

Research output: Contribution to journalArticle

@article{703f0f25c97542a0b6a803e145cdb774,
title = "Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene",
abstract = "Fatty aldehyde dehydrogenase (FALDH) is a microsomal enzyme that catalyzes the oxidation of aliphatic aldehydes to fatty acids. Mutations in the FALDH gene are responsible for the human genetic disorder Sjogren-Larsson syndrome (SLS) which is characterized by ichthyosis, mental retardation, and spasticity. To better understand SLS and the expression of FALDH in mammalian tissues, we investigated the organization and expression of the mouse FALDH gene (recently named ALDH3A2). The mouse gene consists of 11 exons and spans about 25 kb. Primer extension experiments identified the transcription initiation site at nt -121 relative to the translation initiating codon. The major FALDH transcript was 3 kb long and was composed of exons 1-10. A less abundant alternately spliced transcript contained an additional exon (exon 9') inserted between exons 9 and 10 and encodes a protein (FALDHυ) with a variant carboxy-terminal domain of unknown function. Northern analysis using RNA from different tissues showed widespread but variable expression of the gene, which generally correlated with FALDH enzyme activity. Expression of the alternate exon 9' transcript in tissues often differed from that of the major transcript and did not reflect enzyme activity. These results provide a basis for investigating the in vivo expression of FALDH in response to physiologic and pharmacologic manipulation, and are essential for the development of an animal model of SLS. (C) 2000 Academic Press.",
keywords = "Alternate splicing, Enzyme, Fatty aldehyde, Fatty aldehyde dehydrogenase, Ichthyosis, Mental retardation, Sjogren-Larsson syndrome",
author = "Zhili Lin and Gael Carney and Rizzo, {William B}",
year = "2000",
month = "1",
day = "1",
doi = "10.1006/mgme.2000.3084",
language = "English (US)",
volume = "71",
pages = "496--505",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene

AU - Lin, Zhili

AU - Carney, Gael

AU - Rizzo, William B

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Fatty aldehyde dehydrogenase (FALDH) is a microsomal enzyme that catalyzes the oxidation of aliphatic aldehydes to fatty acids. Mutations in the FALDH gene are responsible for the human genetic disorder Sjogren-Larsson syndrome (SLS) which is characterized by ichthyosis, mental retardation, and spasticity. To better understand SLS and the expression of FALDH in mammalian tissues, we investigated the organization and expression of the mouse FALDH gene (recently named ALDH3A2). The mouse gene consists of 11 exons and spans about 25 kb. Primer extension experiments identified the transcription initiation site at nt -121 relative to the translation initiating codon. The major FALDH transcript was 3 kb long and was composed of exons 1-10. A less abundant alternately spliced transcript contained an additional exon (exon 9') inserted between exons 9 and 10 and encodes a protein (FALDHυ) with a variant carboxy-terminal domain of unknown function. Northern analysis using RNA from different tissues showed widespread but variable expression of the gene, which generally correlated with FALDH enzyme activity. Expression of the alternate exon 9' transcript in tissues often differed from that of the major transcript and did not reflect enzyme activity. These results provide a basis for investigating the in vivo expression of FALDH in response to physiologic and pharmacologic manipulation, and are essential for the development of an animal model of SLS. (C) 2000 Academic Press.

AB - Fatty aldehyde dehydrogenase (FALDH) is a microsomal enzyme that catalyzes the oxidation of aliphatic aldehydes to fatty acids. Mutations in the FALDH gene are responsible for the human genetic disorder Sjogren-Larsson syndrome (SLS) which is characterized by ichthyosis, mental retardation, and spasticity. To better understand SLS and the expression of FALDH in mammalian tissues, we investigated the organization and expression of the mouse FALDH gene (recently named ALDH3A2). The mouse gene consists of 11 exons and spans about 25 kb. Primer extension experiments identified the transcription initiation site at nt -121 relative to the translation initiating codon. The major FALDH transcript was 3 kb long and was composed of exons 1-10. A less abundant alternately spliced transcript contained an additional exon (exon 9') inserted between exons 9 and 10 and encodes a protein (FALDHυ) with a variant carboxy-terminal domain of unknown function. Northern analysis using RNA from different tissues showed widespread but variable expression of the gene, which generally correlated with FALDH enzyme activity. Expression of the alternate exon 9' transcript in tissues often differed from that of the major transcript and did not reflect enzyme activity. These results provide a basis for investigating the in vivo expression of FALDH in response to physiologic and pharmacologic manipulation, and are essential for the development of an animal model of SLS. (C) 2000 Academic Press.

KW - Alternate splicing

KW - Enzyme

KW - Fatty aldehyde

KW - Fatty aldehyde dehydrogenase

KW - Ichthyosis

KW - Mental retardation

KW - Sjogren-Larsson syndrome

UR - http://www.scopus.com/inward/record.url?scp=0033739586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033739586&partnerID=8YFLogxK

U2 - 10.1006/mgme.2000.3084

DO - 10.1006/mgme.2000.3084

M3 - Article

VL - 71

SP - 496

EP - 505

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 3

ER -